Finance

Beta
Lists
VNDA:NASDAQ
Vanda Pharmaceuticals Inc.
$5.94
-1.49%
(-0.090) 1D
$5.94
0.00% (0.00)
After hours
Closed: Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VNDA...
Open
$6.11
High
$6.15
Low
$5.92
Mkt. cap
357.21M
Avg. vol.
1.10M
Volume
74.00
52-wk high
$9.94
52-wk low
$4.14
EPS
-$4.05
Beta
0.62
Shares outstanding
60.14M
No. of employees
533
Open
$6.11
High
$6.15
Low
$5.92
Mkt. cap
357.21M
Avg. vol.
1.10M
Volume
74.00
52-wk high
$9.94
52-wk low
$4.14
EPS
-$4.05
Beta
0.62
Shares outstanding
60.14M
No. of employees
533
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to VNDA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for VNDA in the last 3 months.
Highest
Current $5.94
$21.00 (+253.54%)
Average
$19.50 (+228.28%)
Lowest
$18.00 (+203.03%)
News stories
From sources across the web
About Vanda Pharmaceuticals Inc.
CEO-
Employees533
Founded2002
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
52.59M
56.26M
57.22M
51.72M
Cost of goods sold
2.74M
2.95M
3.83M
3.16M
Cost of revenue
2.74M
2.95M
3.83M
3.16M
Research and development expenses
21.99M
22.56M
29.01M
28.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
64.62M
60.27M
62.98M
68.36M
Operating expense
88.36M
84.59M
93.74M
98.78M
Total operating expenses
91.09M
87.54M
97.57M
101.94M
Operating income
-38.50M
-31.28M
-40.35M
-50.22M
Other non operating income
-
-
-
1.80M
EBT including unusual items
-34.89M
-28.39M
-38.00M
-48.42M
EBT excluding unusual items
-34.89M
-28.39M
-40.06M
-48.42M
Income tax expense
-7.68M
-5.80M
103.18M
143.00K
Effective tax rate
22.01%
20.44%
-271.53%
-0.30%
Other operating expenses
-
-
-
-
Net income
-27.21M
-22.59M
-141.19M
-48.57M
Net profit margin
-51.73%
-40.15%
-246.76%
-93.91%
Earnings per share
-
-
-
-
Interest and investment income
3.62M
2.89M
298.00K
-
Interest expense
-
-
-
-
Net interest expenses
3.62M
2.89M
298.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.48M
-29.23M
-38.30M
-47.96M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more